Whether renin is involved in the onset of coronary heart disease (CHD) remains unclear. A case-control study in 1972, suggesting a causal association between renin and CHD, has now been followed by three prospective studies. One was based on 1,717 hypertensive subjects in a Work-Site Program in New York. The main results showed an increased risk of CHD the higher the renin level. A second study in occupational groups in North West London, UK, recruited 803 white men not selected according to blood pressure, and found no association. A possible exception was in the minority of those with similar blood pressure levels to participants in the Work-Site Program, in whom the incidence of CHD was higher according to the renin level, but not significantly so. The third study was in Framingham Offspring and included 3,532 participants also not selected according to blood pressure. As in the UK study, there was no clear association between renin and risk of CHD in all participants, or in this study in those with raised blood pressure. The authors considered their results consistent with those of the UK study in finding "no association of renin with overall risk of CHD". Besides the three epidemiological studies, dealing explicitly with renin, other studies in which it has been one of several variables considered have also not found convincing evidence of its involvement in CHD. There is, therefore, little support for the hypothesis that high renin levels increase the risk of CHD, with the possible but uncertain exception of those with raised blood pressure.
Introduction
Whether renin a plays any causal part in the onset of myocardial infarction (MI) and coronary death, referred to collectively as coronary heart disease (CHD), has remained unresolved since the possibility was suggested in the cross-sectional study by Brunner et al. in 1972 . 1 They reported findings in 219 patients with essential hypertension. They established a nomogram in 52 'normal volunteers'. From this nomogram, renin was 'sub-normal' in 27%, 'normal' in 57% and 'elevated' in 16% of the patients. Of the 38 patients with left ventricular enlargement, those with normal or elevated renin levels had an 11-14% frequency of heart attacks or strokes, respectively, compared with none in the low renin group (p=0.01), but this was based on only 8 heart attacks and 12 strokes. They concluded that patients with low renin activities appeared to have been protected despite similar degrees of hypertension and left ventricular enlargement, and although they were on average older. Renin, they concluded, therefore emerges as a potential risk factor for patients with essential hypertension of potential use for further studying the aetiology of hypertension and its complications, for determining prognosis and in deciding about treatment.
However, while a study of this kind is useful in generating hypotheses, the small numbers involved, particularly of clinical endpoints such as MI, and also the doubtful extent of true comparability between the patients and the normal volunteers, and the setting of arbitrary limits for defining cut-off points in the renin distribution, mean that the results can only be interpreted with great caution. In addition, case-comparison studies are nearly always and inevitably confined to survivors of heart attacks or stroke episodes, virtually the only way of overcoming this difficulty being through prospective studies.
The main purpose of this review is to consider the three large prospective studies that have now been reported, presenting their results and discussing reasons for the apparent differences in these studies.
Plasma renin and the incidence of cardiovascular disease
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Key words: coronary heart disease, myocardial infarction, plasma renin a In this account of the prospective studies, renin is used generically to indicate any method of measuring renin levels or activity. A brief summary of the methods used in each study is given in the sections on individual studies. A full review of different methods used is in the accompanying commentary by Azizi and Menard. Two of the studies were published fairly close to one another, in 1991 2 and 1993. 3 Since their results differed considerably, no clear picture emerged. Interest in the topic has, therefore, been reawakened by the study by Parikh et al. 4 in Framingham Offspring in 2007.
One table from each of the three studies is provided to illustrate the main results. For the WorkSite Programme study by Alderman et al., Table 1 is from a second paper 5 that updates the findings of the first, and therefore has a larger number of outcome events for analysis.
The review is concerned mainly with hard CHD events i.e. supported by good clinical and/or pathological evidence. While the terminology for CHD and other events is basically similar for the studies by Alderman et al. and Meade et al., it differs in the report by Parikh et al., as indicated in the section on the Framingham Offspring study.
Work-Site Program on hypertension Participants
Between 1981 and 1988, Alderman et al. 2 recruited from 3,183 employees entering a union-sponsored Work-Site Program to control hypertension, and selected from those who had untreated systolic blood pressure >160 mmHg, a diastolic blood pressure >95 mmHg or who were taking antihypertensive medication. Blood pressure was recorded by a trained nurse using a standard sphygmomanometer. The average of the second and third readings was considered to be the blood pressure for the day. Blood was drawn in mid-morning while participants were seated, having been ambulatory for at least 2 hours and having been advised to take a moderate sodium diet for the four preceding days. Of those considered, 1,717 met additional criteria for inclusion: a 24-hour urinary secretion of sodium of between 35 and 240 mmol, a renin profile determined within 6 months of entry into the study and a follow-up of at least 2 months after the renin measurement. The 424 participants who did not meet these three criteria and were excluded from analysis were younger by about 2 years but otherwise similar to those with renin determinations who met the criteria. The initial characteristics of the 1,717 participants, of whom about 64% were non-white, and the 1,042 patients for whom a renin profile was unavailable suggested that those studied had a more favourable cardiovascular outlook than those excluded. Participants were encouraged to follow a moderate sodium diet before entry to the study. The renin-sodium (or renin) profile was 'based on a nomogram that had been previously constructed by defining a normal band that included 95% of the reninsodium values of 104 normal subjects'. These high, normal and low renin bands are illustrated graphically in the paper by Alderman et al. according to urinary sodium values.
Renin measurement
Blood for renin was collected into potassium EDTA Vacutainers. Samples were not chilled during processing, stored at between -25°C and -40°C and, when required, rapidly thawed to room temperature in front of a fan. They were incubated at pH 5.7 in the presence of 3 mmol of EDTA and 1.5 mmol of phenylmethylsulfonyl fluoride per litre. Assays 6 were completed within 1-5 days of collection.
Follow up
This was for 8.3 years. New events were first ascertained by a nurse who monitored reports by participants, family members or friends. Hospital and medical records and death certificates were reviewed. Illnesses were classified by the International Classification of Diseases, 9 th revision, the events of main interest being MI and cerebrovascular events. 
Results
The results were published in 1991. 2 Among the 1,717 participants, there were 107 fatal or nonfatal events, 70 cardiovascular, 36 non-cardiovascular and 1 unknown. Of the cardiovascular events, 27 were due to MI. (Apart from the nine fatal MIs, the number of coronary deaths was not given.) There were 211 (12.3%) participants in the high renin profile group, 960 (55.9%) in the normal group and 546 (31.8%) in the low renin profile group. Those with a high renin profile were significantly younger, and more likely to be male and white, compared with those in the normal and low profile groups. The data were analysed extensively taking into account conventional risk factors and the age, ethnic and gender composition of the patients. The incidences of MI adjusted for these variables were 14.7, 5.6 and 2.8 per 1,000 person years in the high, normal and low profile groups, respectively, with a rate ratio between the high and the low profile groups of 5.3 (95% CI 3.4-8.3). There was no association of renin profile with stroke, non-cardiovascular disease (non-CVD) or mortality from all causes. Men, whites, those >55 years of age, smokers, those with cholesterol levels >6.3 mmol per litre and those with fasting glucose levels >7.8 mmol per litre had a higher risk of MI than those who did not have these characteristics. In the entire group of hypertension patients with no additional risk factors, compared with those with one other risk factor, the risks of MI in those with a high renin profile as compared with those with a normal or low renin profile were 7 (p = 0.02) and 2.4 (p = 0.07) times greater, respectively (no CIs given). The results among those treated with β-blockers showed the same relations from high to low as the group as a whole, although the use of β-blockers was associated with an increased incidence of MI. The renin profile was significantly associated with time to MI after all other baseline risk factors had been accounted for.
A further publication based on the same population and methods was published in 1997. 5 There was a larger number of outcome events and Table 1 is based on these. Again, the MI rate was highest in those with high renin levels originally, intermediate in those with normal levels and lowest in those with low levels. There was no evidence of an effect on cerebrovascular disease. The same trend as for MI was seen for total CVD and all-cause mortality, in both of which MI will presumably have been the single largest event.
Although the sample size was fairly large (1,717 participants), the number of outcome events was greatest in those with normal renin levels, the results inevitably being largely influenced by the smaller number of outcome events in those with high or low values. It would have been valuable to know what the results were using actual entry renin levels for each participant.
In summary, the principal finding of the study was that patients with high renin-sodium profiles were at greater risk of MI than those with low or, to a lesser extent, normal profiles. There was no relationship for stroke, nor was there a relation for non-CVD or mortality from all causes.
Northwick Park Heart Study Participants In 1993, Meade et al. 3 reported on 803 white men aged 40-64 years recruited into the Northwick Park Heart Study (NPHS) between 1972 and 1978. All of the men worked daytime hours or shifts in three occupational groups in northwest London, full details of which have been given elsewhere. 7 The men were seen on two consecutive days between 08:00 and 11:00. On the first day, personal and medical histories were obtained. Blood pressure was measured twice to the nearest 2 mmHg, using a random zero sphygmomanometer. The first reading was taken after the participant had been interviewed and seated for about 20 minutes and had lain on a couch for about 5 minutes. The second reading was taken about 5 minutes after the first, the participant having remained recumbent. Results are based on the first of these readings, since the relationship between blood pressure and plasma renin activity was very similar for both readings. On the second day, a blood sample was obtained after the participant, in the fasting state, had been sitting for about 5 minutes, and it was this sample that was used for renin assays, results on which were available for 90% of those taking part. The salt intake of participants had been unrestricted. A clinical diagnosis of hypertension had previously been made in 51 of the 883 men who were screened for the study. Data from these men and from the 29 who had had definite or possible MIs previously are excluded from the analyses, leaving 803 men. The 44 men who had angina pectoris were included.
Renin measurement
Whole blood was drawn into citrate. Plasma was separated and aliquots stored at -20°C as received. They were assayed after being transported to St Mary's Hospital Medical School in 12 separate batches over a 2-year period. The assay method has been described in detail elsewhere. 8 Urinary sodium excretion was not measured.
Follow up
Major coronary events (CHD) were defined as fatal or non-fatal MI and sudden death from coronary causes. Follow-up for the renin study ended in 1991 (although it is continuing for the main study 9 ). Records of all 803 men were flagged in the National Health Service Central Register (NHSCR) which ensures the automatic provision of copies of death certificates. Further information was then obtained from general practitioners, hospitals and coroners. When all available clinical and pathological information had been collected, decisions about the occurrence of MI or sudden coronary death were reviewed by an independent assessor who recorded the diagnosis or cause of death according to WHO criteria.
Statistical analysis
Log-transformed values were used in all analyses, with values for renin adjusted for age. Means were geometric with 95% ranges. Unpaired t-tests were used to test for differences in means and chisquared tests for differences in proportions. The Cox proportional hazards method was used for multivariable analyses. All p-values are two-tailed.
Results
There were 86 incident events of CHD, 35 nonfatal and 51 fatal. As expected, the Cox proportional hazards analysis confirmed a significant, independent association between blood pressure and CHD events. None of the mean values for renin differed significantly between those surviving and still event free compared with those who had incident episodes of CHD. Thus, the renin entry value of 642.8 pmol per litre per hour for those who later died of CHD was virtually identical to the value for those who survived with no events, 674.6 pmol per litre per hour. The value for those who had non-fatal events was a little higher (704.8 pmol per litre per hour), but not significantly. There was a significant inverse correlation between the level of renin and the systolic blood pressure (r = -0.101, p = 0.004) and this correlation was strongest in those whose blood pressures were in the lowest third of the blood pressure distribution. The 26 men who had events within 5 years of entry had higher values for renin (964.0 pmol per litre per hour) than in those in whom events occurred later. However, there was no significant trend towards a higher level of renin with decreasing interval between entry and the occurrence of an event. For summary purposes, Table 2 shows the results of NPHS-I according to three (arbitrary) categories of blood pressure and renin value (each man's individual renin level having been used in analysing the main results already described). There may be a suggestion that those in the highest blood pressure and renin groups experienced the highest rate of major CHD events. However, there was no evidence of an interaction (p = 0.93) between blood pressure and renin in relation to coronary events.
Among NPHS participants, 242 (30%) satisfied the blood pressure criteria of the study by Alderman et al., i.e. systolic blood pressure of ≥160 mmHg or diastolic blood pressure of ≥95 mmHg, and they had 44 of the 86 major events. The relative risk of an event in those in the highest compared with the lowest third of the renin distribution was 1.26 (95% CI 0.63-2.56), i.e. not significantly different. Comparing the top 12% in the renin dis-tribution with the bottom 32% (as in the corresponding analysis by Alderman et al.), the relative risk in NPHS-I was 1.88 (95% CI 0.78-4.54). Thus, while strictly speaking NPHS-I findings on those with raised blood pressure do not exclude a significant effect of renin on CHD, it is unlikely that they demonstrate the same association as in Alderman et al. In NPHS-I men with similar blood pressures to those by which participants in Alderman et al. were selected, and comparing the highest with the lowest third of renin distribution, the relative risk was 1.26 (95% CI 0.63-2.56).
In correspondence following NPHS-I and the Work-Site Program studies, Alderman et al. 10 stated that the NPHS-I results 'in primarily normotensive subjects' were consistent with their own investigation because a high renin-sodium profile was associated with an increased rate of CHD, and that this had been confirmed by NPHS-I, despite non-significant results in the hypertensive participants in NPHS-I. Alderman et al. continued that the failure of NPHS-I to detect an association in 'normotensive' subjects suggested that both high renin and high blood pressure are necessary to produce ischaemic vascular disease, which may Framingham Offspring study Participants The Framingham Offspring study 4 was based on 3,532 participants attending the sixth Offspring examination from 1995 to 1998. After exclusion of 103 participants because of missing plasma renin and 21 with serum creatinine values >2 mg/ dl, 3,408 (53% women) remained eligible for analysis of all-cause mortality risk, including 1,413 individuals with hypertension, i.e. systolic pressure ≥140 mmHg or diastolic ≥90 mmHg or using hypertensive medications. After further exclusion of 190 people with prevalent CVD (see the definitions below), 3,218 remained eligible for the analysis of first CVD incident events, 1,276 with hypertension. Blood pressure was taken after 5 minutes' rest in a chair, and the average of two physician-obtained readings was used.
Renin measurement
Venous blood was collected in a fasting state after supine rest for about 10 minutes, usually between 07:30 and 09:00. Plasma was separated at once and stored at -80°C. Renin was measured with a highly sensitive and specific immunochemiluminometric assay (Nichols Advantage Direct Renin™ assay). Serum aldosterone was also measured.
Follow up
This continued up to December 2004, participants having been under continuous surveillance for death and CVD events. The average follow up period was 7.1 years. Primary outcomes were the incidence of all-cause mortality and the first hard CVD event defined as fatal or non-fatal MI, unstable angina pectoris, stroke or congestive heart failure. Secondary outcomes were (1) first hard CVD as defined, plus stable angina, transient ischaemic attack and intermittent claudication, (2) hard CHD event (i.e. MI or unstable angina) and CHD-death, and (3) CVD-related mortality.
Statistical analysis
Cox proportional hazards regression was used to relate renin to outcome, interaction terms of follow-up time with renin being included to test for proportionality. Analyses were performed for all participants and for the subset of those with hypertension. Relations of renin to outcome at halfyearly intervals up to 5 years were performed if proportionality was not demonstrated. Renin was treated both as a continuous variable (with logarithmic transformation) and as a categorical variable based on gender-specific quartiles defined from the whole sample. Risks in the second, third and fourth quartile of plasma renin were compared with the first quartile and risks were tested for linearity. Multivariable analyses were carried out to adjust for a range of baseline risk factors. Possible effects of anti-inflammatory medication were also taken into account. The assumption of proportionality was not upheld for the primary outcome of all-cause mortality and the secondary outcome of CVD mortality in the whole sample and in hypertensive individuals. There were no effect modifications by age, gender or serum aldosterone.
At a significance level of 0.05, the study had at least 80% power for the main outcomes (hard CVD and all-cause mortality) in the full sample and in the hypertensive sub-sample, assuming 
Results
These were analysed in considerable detail, in terms of different causes of death, confirmation or otherwise of proportionality, the presence or absence of hypertension and the presence or absence of prevalent CVD. Participants in the highest renin quartile were on average younger and more likely to be on treatment for hypertension than those in other quartiles. At follow up, 215 participants (75 women) had died, 127 in the hypertensive sub-group.
All-cause mortality
In Cox analyses that overlooked the failure to demonstrate proportionality, log-renin was associated with increased all-cause mortality among all participants, although the effect (HR 1.14, 95% CI 1.00-1.30) was of marginal statistical significance (p=0.046). Quartile-based analyses also suggested a risk with all-cause mortality but non-significantly (HR 1.27, 95% CI 0.87-1.84; p=0.21). Similar results were obtained among those who were hypertensive. When non-proportionality was allowed for, renin among all participants was associated with an increased risk of all-cause mortality at 0.5 years of follow up, adjusted HR per SD increment in log-renin 1.89 (95% CI 1.31-2.74 p ≤ 0.001) a risk that declined to 1.23 at 2.5 years (p = 0.02) and was statistically non-significant at 3 years.
Hard CVD
At follow-up (mean 7 years, 176 participants (73 women) had experienced a first hard CVD event, (122 in the hypertensive sub-group), and the assumption of proportionality of hazards was met for this endpoint. As Table 3 shows, renin was not associated with the incidence of hard CVD events in the entire sample (nor was it in the subgroup with hypertension). These results were not changed using the broad CVD definition (i.e. that included angina, transient ischaemic attacks and intermittent claudication). Renin was not associated with hard CHD in the whole sample or among those with hypertension, but the data were not shown. Parikh et al. concluded that renin was positively related to all-cause mortality. However, they considered their results 'consistent with the findings of Meade et al…of no association [of renin] with overall risk of CHD'.
Other studies In addition to the three large epidemiological studies discussed, dealing explicitly with renin, there have been other studies in which renin has been one of several variables considered, or in special circumstances. Amongst these has been a study 12 dealing with the prediction of MI by N-terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects who had previously had a stroke or transient ischaemic attack (participants in PROGRESS, the Perindopril Protection against Recurrent Stroke Study). Comparing the highest with the lowest quarters of renin values, there was an odds ratio of 1.7 (95% CI 1.1-2.8) for MI. In a study of multiple biomarkers 13 for the prediction of first major coronary events and death in participants taking part in a routine examination cycle of the Framingham Heart Study, a Cox proportional-hazards analysis, adjusting for other risk factors, found a HR for renin of 1.17 (95% CI 1.1-2.8) per SD. Blumenfeld et al.
14 assessed plasma renin activity in the emergency department for its association with acute MI. In a multivariate analysis, renin as a continuous variable was the dominant independent factor associated with acute MI. In different analyses, odds ratios for the association ranged from 2.7 to 3.4 (p < 0.0001), i.e. an apparently strong relationship. However, as the authors themselves pointed out, heart failure and several medications likely to have been used by the patients concerned may increase plasma renin activity levels.
Discussion
There are several features of the three studies that should be considered in assessing their results on CHD and, in particular, the conclusion by Alderman In terms of size, the study by Alderman et al. was carried out in a group of 1,717 patients selected because of elevated or treated blood pressure levels. As in the case-control study by Brunner et al. 
Adiyaman and Staessen
15 contributed an editorial to accompany publication of the results of the Framingham Offspring study. They emphasised 'the key finding that all-cause mortality increased with higher plasma renin at baseline in the whole sample' as well as in those with hypertension. However, plasma renin did not predict hard cardiovascular or coronary events. They pointed to the advantages of the long follow-up period (although in this respect the study did not differ from the other two), the standardised conditions of blood sampling and the analyses dealing with possible confounding characteristics. On the other hand, renin measurements were not standardised for sodium excretion. Like the other two studies, there were no repeat measurements, so no allowance could be made for regression dilution bias. Adiyaman and Staessen considered that the Framingham results do not support the concept that high circulating renin levels may be a clinically significant predictor of CHD. However, what they felt has 'stood the test of time' is that high renin hypertension, especially among young white patients, should be managed with inhibitors of the renin-angiotensin system.
Azizi and Menard
The predictive value of plasma renin measurement depends on both the quality of the classification of the investigated events-all-cause death being the only one devoid of risk of error-and that of plasma renin measurement. The term plasma renin concentration (PRC) is often confused with the term plasma renin activity (PRA). PRC is determined by an immunoradiometric assay. This assay uses two monoclonal antibodies and measures the number of active renin molecules independently of their enzymatic activity (expressed in pg/ml, IU/L, or pmol/L). 16 PRA describes and quantifies the enzyme's catalytic activity and is determined by the amount of angiotensin I (Ang I) generated per unit of time during incubation of plasma samples in vitro (expressed in pmol or ng of generated Ang I per ml plasma during an incubation period of 1 hour at physiological conditions). Under physiological conditions, PRA is proportional to the concentration of active renin as long as the renin substrate concentration (angiotensinogen) is constant. 17 All prognosis studies have measured either PRA or PRC on a single occasion, and the sources of variability in renin measurements directly influencing the risk of misclassification of the renin status need to be analysed.
Assays as source of error.
The selection of the in vitro method of plasma renin measurement, an enzymatic assay (PRA) or an immunoradiometric assay (PRC) does not normally matter. Indeed, in normotensive healthy subjects as well as in hypertensive patients, both methods of measurements are highly correlated, since the plasma concentration of renin substrate, angiotensinogen, have not such variability that it would notably affect the in vitro and in vivo generation of Ang I. This would not be true in presence of (1) a low concentration of plasma angiotensinogen as observed in patients with severe congestive heart failure or advanced liver cirrhosis or treated with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker plus a diuretic, conditions which can decrease angiotensinogen by 50-80%, or (2) an increase in plasma angiotensinogen by twofold to fivefold induced by synthetic oestrogens prescribed for oral contraception or post-menopausal substitution therapy. 16 Therefore, it is very unlikely that measurement error related to the limiting role of angiotensinogen in PRA assays had an influence on the results of the prognosis studies where the enzymatic assays were used. On the other hand, the sensitivity of the immunoradiometric assays for PRC measurements, which might be less than that of the 
Blood sampling conditions as source of error.
Individual misclassification may exist because of the less strict blood sampling conditions than those theoretically necessary to reduce variability and error such as constant and well-defined daily salt intake, strict control of posture and absence of any drug treatment. 16 For instance, 5-10 minutes rest in the sitting position before blood sampling is shorter than the 1 hour generally used in clinical investigation studies. Under these conditions plasma renin measurements are also influenced by the transportation to the study site, exercise, walking time in the ward, food intake etc. All of these fluctuations increase variability in PRA or PRC measurements and do not allow a precise detection of an association with cardiovascular prognosis, if it exists.
Regression towards the mean as source of misclas-
sification. The regression towards the mean phenomenon may decrease the range of PRA/PRC values but it simultaneously increases the precision of the individual classification. This phenomenon does not influence group classification in low, medium and high renin strata, but may change the classification of an individual subjects when a given threshold has been selected. Indeed, it is certain that if PRA/PRC has been measured on two separate occasions, the same subject may be classified in a different category than they were with the first PRA/PRC determination. For instance, in 100 hypertensive hospitalised patients, PRA was measured in the upright posture on the first and the third day in hospital. The correlation between the two measurements was highly significant (r = 0.793), but when patients were classified in three sub-groups 28 among 100 did not remain in their initial sub-group. 17 Therefore, the Cox models used in the various prognosis studies should include plasma renin as a continuous variable and not as a discontinuous variable to avoid any arbitrary sub-group classification.
